Dilution of equity value resulting from the exercise of stock acquisition rights
First written in FY2022. 8 of 11 entries say "Materialised", first in FY2023-Q1. Latest entry: 2026-09-28.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2024MitigatedAnnual report
「As of the end of July 2024, the number of shares underlying stock acquisition rights was 380,100, representing a potential dilution ratio of 2.76% against the company’s 13,747,000 issued shares.」
The number of shares remaining under stock acquisition rights declined from 481,400 at the end of the previous fiscal year, with a potential dilution ratio of 3.52%, reducing dilution exposure, although the risk itself remains. - FY2024-Q3MaterialisedAnnual report
「This was due to increases of ¥7.727 million each in capital stock and capital surplus from the exercise of stock acquisition rights and the issuance of new shares as restricted stock compensation, while a quarterly net loss of ¥48.073 million was recorded.」
The exercise of stock acquisition rights and the issuance of new shares as restricted stock compensation continued, with potential dilution materializing as actual share issuance. - FY2024-Q2MaterialisedAnnual report
「This was mainly due to proceeds of ¥3.53 million from the issuance of shares through the exercise of stock acquisition rights, while cash outflows of ¥23.748 million resulted from the repayment of long-term borrowings.」
Share issuance through the exercise of stock acquisition rights also occurred during the cumulative second quarter, with the dilution risk materializing as additional share issuance. - FY2024-Q1MaterialisedAnnual report
「1 August 2023–31 October 2023 65,000 13,703,000 1,765 239,103 1,765 139,103」
During the current first quarter, 65,000 shares were issued through the exercise of stock acquisition rights, increasing the total number of issued shares, capital stock and capital surplus. Potential dilution materialized as additional share issuance. - FY2023MaterialisedAnnual report
「As of the end of July 2023, the number of shares underlying stock acquisition rights was 481,400, representing a potential dilution ratio of 3.52% against the company’s 13,638,000 issued shares. If these stock acquisition rights are exercised, the value of the company’s shares may be diluted.」
Share issuance through the exercise of stock acquisition rights occurred again following the previous fiscal year, and 481,400 shares, representing a potential dilution ratio of 3.52%, remained outstanding at the end of the period. - FY2023-Q2MaterialisedAnnual report
「In addition, during the current second quarter accounting period, capital stock and capital surplus each increased by ¥4.03 million as a result of the exercise of stock acquisition rights.」
The exercise of stock acquisition rights continued, increasing capital stock and capital surplus by ¥4.03 million each. On a share-count basis, 402,000 shares were added during the current quarter, resulting in additional dilution risk. - FY2023-Q1MaterialisedAnnual report
「The details of the exercise of stock acquisition rights from 1 November 2022 to 14 December 2022 are as follows: (1) Number of stock acquisition rights exercised: 372; (2) Class and number of shares issued: common shares, 372,000 shares」
The exercise of stock acquisition rights resulted in the issuance of 372,000 shares, and the previously disclosed dilution risk from potential shares materialized as an actual share issuance. - FY2022First statedAnnual report
「As of the end of the month preceding the month in which this document was filed, the number of shares underlying stock acquisition rights was 925,200, representing a potential dilution ratio of 7.54% against the company’s 12,270,000 issued shares. If these stock acquisition rights are exercised, the value of the company’s shares may be diluted.」
The company discloses potential dilution from the exercise of stock options as a risk to shareholder value.